Medistem's Unattributed VC Round

Medistem raised a round of funding on April 24, 2006.

Medistem, Inc. is developing ERC-124, a universal stem cell product derived from the endometrium. ERC-124 possesses specialized abilities to stimulate new blood vessel formation and can differentiate…

Articles about Medistem's Unattributed VC Round: